Indigo Medical merges with imc group

Indigo Medical, a provider of material review, medical signatory approval services and medical communication for global pharmaceutical and biopharma companies, is joining imc group with the backing of pan-European investor Waterland Private Equity.

In a statement the companies said the merger will help imc provide a one-stop service for clients across seven core divisions: Medical & Scientific Content, Publications, Digital & Creative, Insights & Consulting, Patient Engagement, Meetings & Events, and Medical Compliance & Material Review.

Established by pharmaceutical industry veterans, Tina and Rak Patel, Indigo Medical has specialist knowledge in the areas of pharmaceutical material and marketing review, approval process management, and commercial compliance to help clients market the latest treatments and therapies.

The compliance function will be established as a separate entity – Indigo Medical Compliance – to impartially serve the needs of clients.

The financial terms of the transaction were not disclosed.

Co-founder and director of Indigo Medical’s compliance and approval services Rak Patel said: “Our partnership will ensure that more clients can benefit from our many years of experience in providing sector-leading compliance services, simplifying the burden of copy review and approval, and enabling the faster deployment of healthcare solutions.”

Co-founder and director of Indigo Medical’s communication services division Tina Patel said: “Our vision has always been to differentiate our services through world-class scientific know-how and client service.

“We are delighted to have found, in imc group, an organisation that not only shares this philosophy but enables us to expand our geographic footprint, providing a best-in-class service to our clients.”